$7.32
0.070.97%
At close: -
$7.32
0.000.00%
After Hours: 4:00 PM EDT
Comments
Loading...
Cullinan Therapeutics Insider Trading Activity | NASDAQ:CGEM | Benzinga
Track the latest Cullinan Therapeutics insider trading activity. Stay informed on recent buys, sells, and market impact for Cullinan Therapeutics stock.
What is Insider Activity?
Insider trading activity involves company insiders, such as executives, directors, and employees, engaging in transactions of their own company's stock. Insiders' buy and sell transactions provide valuable insights into their confidence in the company's future performance.
What are Cullinan Therapeutics Inc Insiders Doing?
Insiders have report no purchases/sales in the last 30 days.
Notable Recent Insider Buys and Sales
- On February 27, 2025, Jennifer Michaelson, the company's CHIEF SCIENTIFIC OFFICER sold 3.76K shares for $8.53 each.
- On February 27, 2025, Jacquelyn Sumer, the company's CHIEF LEGAL OFFICER sold 3.76K shares for $8.53 each.
- On February 27, 2025, Alan Jeffrey Jones, the company's CHIEF MEDICAL OFFICER sold 4.89K shares for $8.53 each.
Ownership Statistics for Cullinan Therapeutics Inc
Shares Outstanding
58.513M
Insider Shares Owned
3.043M
Insider Percentage Owned
5.20%
Institutional Shares Held
18.203M
Institutional Percentage Held
31.1%
| Feb 27, 2025 | Alan Jeffrey Jones | CHIEF MEDICAL OFFICER | -4.89K | $8.53 | -$41.75K | SELL | -2.73% | 174.16K | Feb 25 | View |
| Feb 27, 2025 | NADIM AHMED | PRESIDENT AND CEO | -12.53K | $8.53 | -$106.87K | SELL | -2.83% | 430.62K | Feb 25 | View |
| Feb 27, 2025 | Jennifer Michaelson | CHIEF SCIENTIFIC OFFICER | -3.76K | $8.53 | -$32.04K | SELL | -2.58% | 142.00K | Feb 25 | View |
| Feb 27, 2025 | Jacquelyn Sumer | CHIEF LEGAL OFFICER | -3.76K | $8.53 | -$32.04K | SELL | -2.67% | 136.90K | Feb 25 | View |
| Jan 07, 2025 | Jennifer Michaelson | CHIEF SCIENTIFIC OFFICER | -4.00K | $12.51 | -$50.04K | SELL | -4.01% | 95.76K | Jan 06 | View |
| Dec 27, 2024 | Nadim Ahmed | PRESIDENT AND CEO | -8.40K | $11.87 | -$99.71K | SELL | -3.09% | 263.15K | Dec 24 | View |
| Dec 20, 2024 | Jennifer Michaelson | CHIEF SCIENTIFIC OFFICER | -4.69K | $11.41 | -$53.55K | SELL | -4.49% | 99.76K | Dec 18 | View |
| Dec 20, 2024 | Alan Jeffrey Jones | CHIEF MEDICAL OFFICER | -4.63K | $11.41 | -$52.85K | SELL | -3.90% | 114.06K | Dec 18 | View |
| Dec 20, 2024 | Jacquelyn Sumer | CHIEF LEGAL OFFICER | -3.48K | $11.41 | -$39.73K | SELL | -3.70% | 90.65K | Dec 18 | View |
| Dec 16, 2024 | Jennifer Michaelson | CHIEF SCIENTIFIC OFFICER | -3.49K | $12.52 | -$43.68K | SELL | -3.23% | 104.45K | Dec 12 | View |
| Nov 07, 2024 | Jennifer Michaelson | CHIEF SCIENTIFIC OFFICER | -8.00K | $15.64 | -$125.12K | SELL | -6.90% | 107.94K | Nov 05 | View |
| Sep 09, 2024 | Jennifer Michaelson | CHIEF SCIENTIFIC OFFICER | -8.00K | $18.09 | -$144.72K | SELL | -6.45% | 115.94K | Sep 05 | View |
| Jul 09, 2024 | Jennifer Michaelson | CHIEF SCIENTIFIC OFFICER | -8.00K | $16.33 | -$130.64K | SELL | -6.06% | 123.94K | Jul 05 | View |
| May 08, 2024 | Jennifer Michaelson | CHIEF SCIENTIFIC OFFICER | -8.00K | $16.27 | -$1.56M | SELL | -5.81% | 129.58K | May 06 - May 07 | View |
| Feb 02, 2024 | Corrine Savill | CHIEF BUSINESS OFFICER | 0.00 | $10.24 | -$475.20K | SELL-OPTIONS | 0.00% | 165.99K | Feb 01 | View |
| Jan 30, 2024 | Corrine Savill | CHIEF BUSINESS OFFICER | 0.00 | $9.20 | -$391.60K | SELL-OPTIONS | 0.00% | 165.99K | Jan 29 | View |
| Jan 24, 2024 | Corrine Savill | CHIEF BUSINESS OFFICER | -4.13K | $8.31 | -$338.25K | SELL | -2.42% | 165.99K | Jan 22 - Jan 23 | View |
| Dec 27, 2023 | NADIM AHMED | PRESIDENT AND CEO | -4.27K | $9.24 | -$39.47K | SELL | -3.69% | 111.55K | Dec 26 | View |
| Dec 22, 2023 | Alan Jeffrey Jones | CHIEF MEDICAL OFFICER | -1.86K | $8.50 | -$15.81K | SELL | -3.20% | 56.19K | Dec 21 | View |
| Dec 22, 2023 | Jacquelyn Sumer | CHIEF LEGAL OFFICER | -1.40K | $8.50 | -$11.90K | SELL | -3.07% | 44.13K | Dec 21 | View |
| Dec 22, 2023 | Jeffrey Trigilio | CHIEF FINANCIAL OFFICER | -1.92K | $8.50 | -$16.32K | SELL | -2.24% | 83.92K | Dec 21 | View |
| Dec 22, 2023 | Jennifer Michaelson | CHIEF SCIENTIFIC OFFICER | -1.15K | $8.50 | -$9.73K | SELL | -1.29% | 87.58K | Dec 21 | View |
| Dec 20, 2023 | Alan Jeffrey Jones | CHIEF MEDICAL OFFICER | -386.00 | $8.22 | -$3.17K | SELL | -0.66% | 58.05K | Dec 18 | View |
| Dec 20, 2023 | Jennifer Michaelson | CHIEF SCIENTIFIC OFFICER | -238.00 | $8.22 | -$1.96K | SELL | -0.27% | 88.73K | Dec 18 | View |
| Dec 20, 2023 | Jacquelyn Sumer | CHIEF LEGAL OFFICER | -290.00 | $8.22 | -$2.38K | SELL | -0.63% | 45.53K | Dec 18 | View |
| Dec 20, 2023 | Jeffrey Trigilio | CHIEF FINANCIAL OFFICER | -398.00 | $8.22 | -$3.27K | SELL | -0.46% | 85.84K | Dec 18 | View |
| Dec 13, 2023 | Jeffrey Trigilio | CHIEF FINANCIAL OFFICER | -1.93K | $7.81 | -$15.04K | SELL | -2.18% | 86.24K | Dec 12 | View |
| Dec 13, 2023 | Jennifer Michaelson | CHIEF SCIENTIFIC OFFICER | -1.07K | $7.81 | -$8.34K | SELL | -1.19% | 88.97K | Dec 12 | View |
| Jun 29, 2023 | NADIM AHMED | PRESIDENT AND CEO | -759.00 | $11.40 | -$8.65K | SELL | -0.65% | 115.82K | Jun 28 | View |
| Jun 21, 2023 | Alan Jeffrey Jones | CHIEF MEDICAL OFFICER | -387.00 | $12.94 | -$5.01K | SELL | -0.66% | 58.44K | Jun 20 | View |
| Jun 21, 2023 | Jennifer Michaelson | CHIEF DEVELOPMENT OFFICER | -238.00 | $12.94 | -$3.08K | SELL | -0.26% | 90.03K | Jun 20 | View |
| Jun 21, 2023 | Jeffrey Trigilio | CHIEF FINANCIAL OFFICER | -399.00 | $12.94 | -$5.16K | SELL | -0.46% | 85.82K | Jun 20 | View |
| Jun 21, 2023 | Jacquelyn Sumer | CHIEF LEGAL OFFICER | -291.00 | $12.94 | -$3.77K | SELL | -0.63% | 45.82K | Jun 20 | View |
| Jun 14, 2023 | Jeffrey Trigilio | CHIEF FINANCIAL OFFICER | -319.00 | $13.11 | -$4.18K | SELL | -0.37% | 86.22K | Jun 12 | View |
| Jun 14, 2023 | Jennifer Michaelson | CHIEF DEVELOPMENT OFFICER | -176.00 | $13.11 | -$2.31K | SELL | -0.19% | 90.27K | Jun 12 | View |
| Jun 08, 2023 | Jennifer Michaelson | CHIEF DEVELOPMENT OFFICER | 0.00 | $8.31 | -$96.13K | SELL-OPTIONS | 0.00% | 90.45K | Jun 06 - Jun 07 | View |
| May 24, 2023 | NADIM AHMED | PRESIDENT AND CEO | -707.00 | $9.15 | -$6.47K | SELL | -0.60% | 116.58K | May 23 | View |
| May 19, 2023 | Jennifer Michaelson | CHIEF DEVELOPMENT OFFICER | -239.00 | $8.76 | -$2.09K | SELL | -0.26% | 90.45K | May 18 | View |
| May 19, 2023 | Alan Jeffrey Jones | CHIEF MEDICAL OFFICER | -394.00 | $8.76 | -$3.45K | SELL | -0.67% | 58.82K | May 18 | View |
| May 19, 2023 | Jacquelyn Sumer | CHIEF LEGAL OFFICER | -291.00 | $8.76 | -$2.55K | SELL | -0.63% | 46.11K | May 18 | View |
| May 19, 2023 | Jeffrey Trigilio | CHIEF FINANCIAL OFFICER | -399.00 | $8.76 | -$3.50K | SELL | -0.46% | 86.54K | May 18 | View |
| May 16, 2023 | Jennifer Michaelson | CHIEF DEVELOPMENT OFFICER | -193.00 | $8.78 | -$1.69K | SELL | -0.21% | 90.69K | May 12 | View |
| May 16, 2023 | Jeffrey Trigilio | CHIEF FINANCIAL OFFICER | -347.00 | $8.78 | -$3.05K | SELL | -0.40% | 86.94K | May 12 | View |
| Apr 26, 2023 | NADIM AHMED | PRESIDENT AND CEO | -716.00 | $10.59 | -$7.58K | SELL | -0.61% | 117.29K | Apr 25 | View |
| Apr 20, 2023 | Alan Jeffrey Jones | CHIEF MEDICAL OFFICER | -392.00 | $10.71 | -$4.20K | SELL | -0.66% | 59.22K | Apr 18 | View |
| Apr 20, 2023 | Jeffrey Trigilio | CHIEF FINANCIAL OFFICER | -398.00 | $10.71 | -$4.26K | SELL | -0.45% | 87.29K | Apr 18 | View |
| Apr 20, 2023 | Jennifer Michaelson | CHIEF DEVELOPMENT OFFICER | -238.00 | $10.71 | -$2.55K | SELL | -0.26% | 90.88K | Apr 18 | View |
| Apr 20, 2023 | Jacquelyn Sumer | CHIEF LEGAL OFFICER | -290.00 | $10.71 | -$3.11K | SELL | -0.62% | 46.41K | Apr 18 | View |
| Apr 14, 2023 | Jeffrey Trigilio | CHIEF FINANCIAL OFFICER | -318.00 | $10.22 | -$3.25K | SELL | -0.36% | 87.69K | Apr 12 | View |
| Apr 14, 2023 | Jennifer Michaelson | CHIEF DEVELOPMENT OFFICER | -176.00 | $10.22 | -$1.80K | SELL | -0.19% | 91.12K | Apr 12 | View |
| Mar 27, 2023 | Jeffrey Trigilio | CHIEF FINANCIAL OFFICER | -399.00 | $11.32 | -$4.52K | SELL | -0.45% | 88.00K | Mar 20 | View |
| Mar 27, 2023 | Alan Jeffrey Jones | CHIEF MEDICAL OFFICER | -390.00 | $11.32 | -$4.41K | SELL | -0.65% | 59.61K | Mar 20 | View |
| Mar 27, 2023 | Jennifer Michaelson | CHIEF DEVELOPMENT OFFICER | -238.00 | $11.32 | -$2.69K | SELL | -0.26% | 91.29K | Mar 20 | View |
| Mar 27, 2023 | Jacquelyn Sumer | CHIEF LEGAL OFFICER | -305.00 | $11.32 | -$3.45K | SELL | -0.65% | 46.70K | Mar 20 | View |
| Mar 27, 2023 | NADIM AHMED | PRESIDENT AND CEO | -706.00 | $10.51 | -$7.42K | SELL | -0.59% | 118.00K | Mar 23 | View |
| Nov 29, 2022 | Jennifer Michaelson | SEE REMARKS | 0.00 | $8.80 | -$36.00K | SELL-OPTIONS | 0.00% | 53.03K | Nov 25 | View |
| Sep 29, 2022 | Jennifer Michaelson | SEE REMARKS | 0.00 | $8.35 | -$32.40K | SELL-OPTIONS | 0.00% | 53.03K | Sep 27 | View |
| Aug 09, 2022 | Jennifer Michaelson | CHIEF DEVELOPMENT OFFICER | 0.00 | $9.65 | -$14.83K | SELL-OPTIONS | 0.00% | 53.03K | Aug 08 | View |
| Aug 04, 2022 | SCS VisionMorana JovanEmbiricos | 10% OWNER | -49.91K | $14.26 | -$711.68K | SELL | -3.30% | 1.46M | Aug 02 - Aug 04 | View |
| Jul 26, 2022 | Jennifer Michaelson | CHIEF DEVELOPMENT OFFICER | 0.00 | $9.40 | -$81.68K | SELL-OPTIONS | 0.00% | 53.03K | Jul 25 | View |
| Jul 21, 2022 | Corrine Savill | ACTING CHIEF BUSINESS OFFICER | -20.00K | $15.18 | -$303.59K | SELL | -11.79% | 149.62K | Jul 18 - Jul 19 | View |
| Jul 12, 2022 | Corrine Savill | ACTING CHIEF BUSINESS OFFICER | -40.00K | $13.33 | -$533.30K | SELL | -19.08% | 169.62K | Jul 11 | View |
| Jun 23, 2022 | F Bioscience I LtdMorana JovanEmbiricos | 10% OWNER | -101.90K | $12.80 | -$1.30M | SELL | -13.55% | 649.90K | Jun 21 - Jun 23 | View |
| Jun 07, 2022 | NADIM AHMED | PRESIDENT AND CEO | 8.09K | $12.40 | $100.32K | BUY | ∞ | 8.09K | Jun 06 | View |
| Jun 03, 2022 | BVF PARTNERS L PILBIOTECHNOLOGY VALUE FUND L PBVF I GP LLCBIOTECHNOLOGY VALUE FUND II LPBVF II GP LLCBiotechnology Value Trading Fund OS LPBVF Partners OS LtdBVF GP HOLDINGS LLCINCIL BVFMARK LAMPERT | 10% OWNER | 751.40K | $11.00 | $8.26M | BUY | ∞ | 364.16K | Jun 01 | View |
| May 16, 2022 | SCS VisionMorana JovanEmbiricos | 10% OWNER | -418.74K | $9.66 | -$4.05M | SELL | -22.79% | 1.42M | May 12 - May 16 | View |
| May 16, 2022 | BVF PARTNERS L PILBIOTECHNOLOGY VALUE FUND L PBVF I GP LLCBIOTECHNOLOGY VALUE FUND II LPBVF II GP LLCBiotechnology Value Trading Fund OS LPBVF Partners OS LtdBVF GP HOLDINGS LLCINCIL BVFMARK LAMPERT | 10% OWNER | 1.11M | $9.07 | $10.06M | BUY | ∞ | 319.42K | May 12 - May 13 | View |
| Apr 05, 2022 | BVF PARTNERS L PILBIOTECHNOLOGY VALUE FUND L PBVF I GP LLCBIOTECHNOLOGY VALUE FUND II LPBVF II GP LLCBiotechnology Value Trading Fund OS LPBVF Partners OS LtdBVF GP HOLDINGS LLCINCIL BVFMARK LAMPERT | 10% OWNER | 276.00K | $10.75 | $2.97M | BUY | 12.42% | 2.50M | Apr 01 | View |
| Oct 20, 2021 | Jennifer Michaelson | SEE REMARKS | 0.00 | $12.86 | -$68.47K | SELL-OPTIONS | 0.00% | 22.91K | Oct 18 | View |
| Oct 18, 2021 | Jeffrey Trigilio | CHIEF FINANCIAL OFFICER | 0.00 | $14.65 | -$165.60K | SELL-OPTIONS | 0.00% | 2.25K | Oct 15 | View |
| Oct 18, 2021 | Leigh Zawel | SEE REMARKS | -19.57K | $25.00 | -$489.35K | SELL | -34.43% | 37.28K | Oct 15 | View |
| Oct 12, 2021 | Leigh Zawel | SEE REMARKS | -1.08K | $25.00 | -$26.98K | SELL | -1.86% | 56.86K | Oct 07 | View |
| Sep 21, 2021 | Jennifer Michaelson | SEE REMARKS | 0.00 | $14.41 | -$80.85K | SELL-OPTIONS | 0.00% | 22.91K | Sep 20 | View |
| Sep 21, 2021 | Leigh Zawel | SEE REMARKS | -7.47K | $25.16 | -$187.89K | SELL | -11.42% | 57.94K | Sep 20 | View |
| Sep 20, 2021 | UBS Oncology Impact Fund LPOncology Impact Fund Cayman Management LPBioImpact Capital LLC | 10% OWNER | -3.12K | $29.06 | -$90.78K | SELL | -0.04% | 7.65M | Sep 16 | View |
| Sep 20, 2021 | Ansbert Gadicke | DIRECTOR | -3.56K | $29.06 | -$103.34K | SELL | -0.05% | 7.65M | Sep 16 | View |
| Sep 16, 2021 | UBS Oncology Impact Fund LPOncology Impact Fund Cayman Management LPBioImpact Capital LLC | 10% OWNER | -13.53K | $29.17 | -$394.64K | SELL | -0.18% | 7.65M | Sep 14 - Sep 15 | View |
| Sep 16, 2021 | Ansbert Gadicke | DIRECTOR | -15.40K | $29.17 | -$449.17K | SELL | -0.20% | 7.65M | Sep 14 - Sep 15 | View |
| Sep 13, 2021 | UBS Oncology Impact Fund LPOncology Impact Fund Cayman Management LPBioImpact Capital LLC | 10% OWNER | -23.25K | $29.23 | -$679.74K | SELL | -0.30% | 7.66M | Sep 09 - Sep 13 | View |
| Sep 13, 2021 | Ansbert Gadicke | DIRECTOR | -26.47K | $29.23 | -$773.72K | SELL | -0.34% | 7.66M | Sep 09 - Sep 13 | View |
| Sep 09, 2021 | Patrick Baeuerle | SEE REMARKS | 0.00 | $16.38 | -$265.65K | SELL-OPTIONS | 0.00% | 341.43K | Sep 08 | View |
| Sep 09, 2021 | Jeffrey Trigilio | CHIEF FINANCIAL OFFICER | 0.00 | $16.39 | -$362.65K | SELL-OPTIONS | 0.00% | 2.25K | Sep 08 | View |
| Sep 08, 2021 | UBS Oncology Impact Fund LPOncology Impact Fund Cayman Management LPBioImpact Capital LLC | 10% OWNER | -48.64K | $29.20 | -$1.42M | SELL | -0.63% | 7.69M | Sep 03 - Sep 08 | View |
| Sep 08, 2021 | Ansbert Gadicke | DIRECTOR | -55.36K | $29.20 | -$1.62M | SELL | -0.71% | 7.69M | Sep 03 - Sep 08 | View |
| Sep 08, 2021 | Leigh Zawel | SEE REMARKS | -28.12K | $28.95 | -$814.02K | SELL | -30.07% | 65.41K | Sep 07 | View |
| Sep 02, 2021 | UBS Oncology Impact Fund LPOncology Impact Fund Cayman Management LPBioImpact Capital LLC | 10% OWNER | -24.31K | $29.50 | -$717.22K | SELL | -0.31% | 7.74M | Aug 31 - Sep 02 | View |
| Sep 02, 2021 | Ansbert Gadicke | DIRECTOR | -27.67K | $29.50 | -$816.35K | SELL | -0.36% | 7.74M | Aug 31 - Sep 02 | View |
| Aug 31, 2021 | Ansbert Gadicke | DIRECTOR | -50.49K | $29.24 | -$1.48M | SELL | -0.65% | 7.76M | Aug 27 - Aug 30 | View |
| Aug 31, 2021 | UBS Oncology Impact Fund LPOncology Impact Fund Cayman Management LPBioImpact Capital LLC | 10% OWNER | -44.36K | $29.24 | -$1.30M | SELL | -0.57% | 7.76M | Aug 27 - Aug 30 | View |
| Aug 26, 2021 | Patrick Baeuerle | SEE REMARKS | 0.00 | $15.65 | -$249.70K | SELL-OPTIONS | 0.00% | 341.43K | Aug 10 | View |
| Aug 25, 2021 | UBS Oncology Impact Fund LPOncology Impact Fund Cayman Management LPMPM Oncology Impact Management GP LLCMPM Oncology Impact Management LP | 10% OWNER | -105.89K | $29.29 | -$3.10M | SELL | -1.34% | 7.81M | Aug 23 - Aug 25 | View |
| Aug 25, 2021 | Ansbert Gadicke | DIRECTOR | -120.59K | $29.29 | -$3.53M | SELL | -1.52% | 7.81M | Aug 23 - Aug 25 | View |
| Aug 24, 2021 | Leigh Zawel | SEE REMARKS | -28.12K | $29.00 | -$815.42K | SELL | -23.12% | 93.52K | Aug 23 | View |
| Aug 24, 2021 | Jennifer Michaelson | SEE REMARKS | 0.00 | $15.98 | -$93.45K | SELL-OPTIONS | 0.00% | 22.91K | Aug 18 | View |
| Aug 12, 2021 | UBS Oncology Impact Fund LPOncology Impact Fund Cayman Management LPMPM Oncology Impact Management GP LLCMPM Oncology Impact Management LP | 10% OWNER | -2.51K | $29.05 | -$72.92K | SELL | -0.03% | 7.91M | Aug 11 | View |
| Aug 12, 2021 | Ansbert Gadicke | DIRECTOR | -2.86K | $29.05 | -$83.00K | SELL | -0.04% | 7.91M | Aug 11 | View |
| Aug 11, 2021 | Leigh Zawel | SEE REMARKS | -28.12K | $26.77 | -$752.85K | SELL | -18.78% | 121.64K | Aug 09 - Aug 10 | View |
| Jan 14, 2021 | UBS Oncology Impact Fund LPOncology Impact Fund Cayman Management LPMPM Oncology Impact Management GP LLCMPM Oncology Impact Management LP | 10% OWNER | 7.91M | $21.00 | $6.30M | BUY | ∞ | 7.91M | Jan 12 | View |
| Jan 14, 2021 | Ansbert Gadicke | DIRECTOR | 8.20M | $21.00 | $6.30M | BUY | ∞ | 7.91M | Jan 07 - Jan 12 | View |
| Jan 14, 2021 | Morana JovanEmbiricosGlobeways Holdings LtdSCS VisionF Bioscience I LtdF MG LtdF TPO Investments LLCF Bio TD LLCF MC LLCF GC LLC | DIRECTOR | 6.03M | $21.00 | $4.20M | BUY | ∞ | 217.27K | Jan 12 | View |
| Jan 14, 2021 | Owen Hughes | PRESIDENT AND CEO | 2.50K | $21.00 | $52.50K | BUY | 0.50% | 506.23K | Jan 12 | View |
| Jan 14, 2021 | Jeffrey Trigilio | CHIEF FINANCIAL OFFICER | 2.25K | $21.00 | $47.25K | BUY | ∞ | 2.25K | Jan 12 | View |
FAQ
Is insider trading legal?
Insider trading is legal so long as the insiders report those trades to the SEC. Illegal securities trading occurs when the insider is violating a fiduciary duty or fails to report their trades.
What are some examples of market manipulation?
Insider trading, pump and dump schemes, front running and wash trades are all examples of market manipulation. Investors who track insider asset movement should think carefully about why these insiders are trading their stocks before moving forward.
Browse insider trades on all stocks.